How point-of-care testing could drive innovation in global health
N. Engl. j. med
; 368(24): 2319-2324, jun.13.2023. ilus
Article
in En
| AIM, RSDM, SES-SP
| ID: biblio-1524771
Responsible library:
MZ1.1
ABSTRACT
The investment in health services in low- and middle-income countries has increased substantially in recent years.1 Such investment has been led by unprecedented efforts to combat major diseases, enabled by the availability of lower-cost and effective drug regimens for treatment and prophylaxis, along with improved vector control. As health services have expanded, so has the demand for diagnostic tests that are essential in identifying patients, determining prognosis, monitoring treatment, and assessing the efficacy of prevention.
Full text:
1
Collection:
06-national
/
BR
Database:
AIM
/
RSDM
/
SES-SP
Main subject:
Global Health
/
Delivery of Health Care
Type of study:
Diagnostic_studies
Aspects:
Determinantes_sociais_saude
Limits:
Female
/
Humans
/
Male
Country/Region as subject:
Africa
Language:
En
Journal:
N. Engl. j. med
Year:
2023
Document type:
Article